To better understand the stage(s) of differentiation reached by B-type chronic lymphocytic leukemia (B-CLL) cells and to gain insight into the potential role of antigenic stimulation in the development and diversification of these cells, we analyzed the rearranged VH genes expressed by 83 B-CLL cells (64 IgM+ and 19 non-IgM+). Our results confirm and extend the observations of a bias in the use of certain VH, D, and JH genes among B-CLL cells. In addition, they indicate that the VH genes of approximately 50% of the IgM+ B-CLL cells and approximately 75% of the non-IgM+ B-CLL cells can exhibit somatic mutations. The presence of mutation varies according to the VH family expressed by the B-CLL cell (VH3 expressers displaying more mutation than VH1 and VH4 expressers). In addition, the extent of mutation can be sizeable with approximately 32% of the IgM+ cases and approximately 68% of the non-IgM+ cases differing by > 5% from the most similar germline gene. Approximately 20% of the mutated VH genes display replacement mutations in a pattern consistent with antigen selection. However, CDR3 characteristics (D and JH gene use and association and HCDR3 length, composition, and charge) suggest that selection for distinct B cell receptors (BCR) occurs in many more B-CLL cells. Based on these data, we suggest three prototypic BCR, representing the VH genes most frequently encountered in our study. These data suggest that many B-CLL cells have been previously stimulated, placing them in the "experienced" or "memory" CD5(+) B cell subset.
F Fais, F Ghiotto, S Hashimoto, B Sellars, A Valetto, S L Allen, P Schulman, V P Vinciguerra, K Rai, L Z Rassenti, T J Kipps, G Dighiero, H W Schroeder Jr, M Ferrarini, N Chiorazzi
Title and authors | Publication | Year |
---|---|---|
Lymphoma: Methods and Protocols
R Küppers |
2019 | |
Lymphoma: Methods and Protocols
R Küppers |
2019 | |
BCR-associated factors driving chronic lymphocytic leukemia cells proliferation ex vivo
C Schleiss, W Ilias, O Tahar, Y Güler, L Miguet, C Mayeur-Rousse, L Mauvieux, LM Fornecker, E Toussaint, R Herbrecht, F Bertrand, M Maumy-Bertrand, T Martin, S Fournel, P Georgel, S Bahram, L Vallat |
Scientific Reports | 2019 |
Another step forward in the 20-year history of IGHV mutations in chronic lymphocytic leukemia
ID Giudice, R Foà |
Haematologica | 2019 |
A practical guide for mutational signature analysis in hematological malignancies
F Maura, A Degasperi, F Nadeu, D Leongamornlert, H Davies, L Moore, R Royo, B Ziccheddu, XS Puente, H Avet-Loiseau, PJ Campbell, S Nik-Zainal, E Campo, N Munshi, N Bolli |
Nature Communications | 2019 |
Distinct immunoglobulin heavy chain variable region gene repertoire and lower frequency of del(11q) in Taiwanese patients with chronic lymphocytic leukaemia
YJ Huang, MC Kuo, H Chang, PN Wang, JH Wu, YM Huang, MC Ma, TC Tang, CY Kuo, LY Shih |
British Journal of Haematology | 2019 |
Integrated epigenomic and transcriptomic analysis reveals TP63 as a novel player in clinically aggressive chronic lymphocytic leukemia: TP63 in CLL
N Papakonstantinou, S Ntoufa, M Tsagiopoulou, T Moysiadis, S Bhoi, A Malousi, F Psomopoulos, L Mansouri, S Laidou, D Papazoglou, M Gounari, K Pasentsis, K Plevova, V Kuci-Emruli, M Duran-Ferrer, Z Davis, S Ek, D Rossi, G Gaidano, M Ritgen, D Oscier, N Stavroyianni, S Pospisilova, F Davi, P Ghia, A Hadzidimitriou, C Belessi, JI Martin-Subero, C Pott, R Rosenquist, K Stamatopoulos |
International Journal of Cancer | 2019 |
Updates in the management of chronic lymphocytic leukemia/small lymphocytic leukemia
KS Hanna |
Journal of Oncology Pharmacy Practice | 2019 |
The B‐cell receptor in control of tumor B‐cell fitness: Biology and clinical relevance
S Casola, L Perucho, C Tripodo, P Sindaco, M Ponzoni, F Facchetti |
Immunological Reviews | 2019 |
98% IGHV gene identity is the optimal cutoff to dichotomize the prognosis of Chinese patients with chronic lymphocytic leukemia
K Shi, Q Sun, C Qiao, H Zhu, L Wang, J Wu, L Wang, J Fu, KH Young, L Fan, Y Xia, W Xu, J Li |
Cancer Medicine | 2019 |
The Impact and Prognostic Significance of Chronic Lymphocytic Leukemia Upregulated 1 (CLLU1) Gene Expression in Patients with Chronic Lymphocytic Leukemia: A Single Center Experience
M Sevinc, A Karabulut, AE Eskazan, SC Tatonyan, U Ozbek, T Soysal |
Laboratory Medicine | 2019 |